Aster DM Healthcare Past Earnings Performance
Past criteria checks 1/6
Aster DM Healthcare's earnings have been declining at an average annual rate of -1.2%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been declining at an average rate of 3.5% per year. Aster DM Healthcare's return on equity is 8.2%, and it has net margins of 5.6%.
Key information
-1.2%
Earnings growth rate
-1.1%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -3.5% |
| Return on equity | 8.2% |
| Net Margin | 5.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Aster DM Healthcare's (NSE:ASTERDM) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Oct 31
Here's What's Concerning About Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital
Oct 14Aster DM Healthcare Limited's (NSE:ASTERDM) Popularity With Investors Is Under Threat From Overpricing
Jul 20Capital Allocation Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Ideal
Jun 23Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt
May 30With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For
Apr 14Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 27Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 12Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly
Feb 07There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital
Jan 19Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)?
Apr 03Is Aster DM Healthcare Limited (NSE:ASTERDM) Trading At A 42% Discount?
Mar 02Should You Investigate Aster DM Healthcare Limited (NSE:ASTERDM) At ₹186?
Dec 17Revenue & Expenses Breakdown
How Aster DM Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 40,166 | 2,261 | 10,620 | 0 |
| 30 Jun 24 | 38,596 | 1,667 | 8,573 | 0 |
| 31 Mar 24 | 36,989 | 1,224 | 9,831 | 0 |
| 31 Dec 23 | 135,049 | 3,241 | 15,571 | 0 |
| 30 Sep 23 | 129,865 | 2,843 | 14,933 | 0 |
| 30 Jun 23 | 124,861 | 3,613 | 14,479 | 0 |
| 31 Mar 23 | 29,941 | 1,090 | 7,553 | 0 |
| 31 Dec 22 | 113,984 | 4,804 | 11,987 | 0 |
| 30 Sep 22 | 108,558 | 4,894 | 11,485 | 0 |
| 30 Jun 22 | 105,438 | 5,501 | 10,954 | 0 |
| 31 Mar 22 | 102,533 | 5,260 | 10,726 | 0 |
| 31 Dec 21 | 99,164 | 4,051 | 9,408 | 0 |
| 30 Sep 21 | 94,944 | 3,492 | 9,003 | 0 |
| 30 Jun 21 | 92,329 | 2,751 | 8,732 | 0 |
| 31 Mar 21 | 86,084 | 1,477 | 8,041 | 0 |
| 31 Dec 20 | 85,886 | 1,735 | 1,425 | 0 |
| 30 Sep 20 | 86,514 | 2,202 | 1,480 | 0 |
| 30 Jun 20 | 84,705 | 1,904 | 1,485 | 0 |
| 31 Mar 20 | 86,519 | 2,766 | 8,826 | 0 |
| 31 Dec 19 | 86,382 | 3,548 | 5,074 | 0 |
| 30 Sep 19 | 84,666 | 3,161 | 4,852 | 0 |
| 30 Jun 19 | 82,167 | 3,240 | 4,557 | 0 |
| 31 Mar 19 | 79,627 | 3,331 | 4,342 | 0 |
| 31 Dec 18 | 75,460 | 3,139 | 4,772 | 0 |
| 30 Sep 18 | 72,102 | 3,687 | 4,544 | 0 |
| 30 Jun 18 | 69,394 | 3,582 | 4,391 | 0 |
| 31 Mar 18 | 67,212 | 2,689 | 4,225 | 0 |
| 31 Mar 17 | 59,313 | 1,018 | 4,120 | 0 |
| 31 Mar 16 | 52,499 | -590 | 2,995 | 0 |
| 31 Mar 15 | 38,758 | 1,327 | 1,798 | 0 |
| 31 Mar 14 | 28,711 | 1,778 | 1,221 | 0 |
Quality Earnings: ASTERDM has a high level of non-cash earnings.
Growing Profit Margin: ASTERDM's current net profit margins (5.6%) are higher than last year (2.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ASTERDM's earnings have declined by 1.2% per year over the past 5 years.
Accelerating Growth: ASTERDM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ASTERDM had negative earnings growth (-20.5%) over the past year, making it difficult to compare to the Healthcare industry average (33.2%).
Return on Equity
High ROE: ASTERDM's Return on Equity (8.2%) is considered low.